1: Conditional resolution to enter into a legal merger of CureVac N.V. with and into CureVac Merger B.V. – Against (434.740)
2: Conditional resolution to approve (i) the Legal Downstream Merger, (ii) the subsequent sale and transfer of all outstanding shares in the capital of CureVac SE by CureVac Merger B.V. to BioNTech SE and (iii) the subsequent cancellation of all outstanding class A shares in the capital of CureVac Merger B.V. – Against (434.740)
3: Conditional release of managing directors from liability for the exercise of their duties – For (434.740)
4: Conditional release of supervisory directors from liability for the exercise of their duties – For (434.740)
5: Conditional appointment of Ramón Zapata Gomez as managing director of CureVac N.V. – For (434.740)
6: Conditional appointment of Sierk Poetting as supervisory director of CureVac N.V. – For (434.740)
7: Conditional appointment of James Ryan as supervisory director of CureVac N.V. – For (434.740)
8: Conditional appointment of Annemarie Hanekamp as supervisory director of CureVac N.V. – For (434.740)
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial’s solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.